Top HCG Brands: A Spotlight on Excellence

In recent years, the popularity of Human Chorionic Gonadotropin (HCG) as a weight loss supplement has surged, leading to a variety of brands flooding the market. With numerous choices available, choosing the right HCG product can be a daunting task for consumers seeking effective and safe results. Whether you're interested in injections, drops, or tablets, finding a reputable brand that adheres to quality and safety standards is crucial. To guide you through your decision-making process, we have compiled a comprehensive list of the best HCG brands currently available. Explore the options below to find a brand that suits your needs and lifestyle.

Illustration of hcg

Best brands of hcg in 2025

Pregnyl

Pregnyl, a brand of human chorionic gonadotropin (hCG), is a highly effective and widely used medication for inducing ovulation and treating infertility. Produced by Organon USA Inc., a subsidiary of Merck & Co., Inc., Pregnyl is derived from the urine of pregnant women and contains 10,000 USP units of chorionic gonadotropin per vial. It mimics the action of luteinizing hormone (LH) and also has some follicle-stimulating hormone (FSH) activity, making it crucial for stimulating the production of gonadal steroid hormones. For detailed information on Pregnyl, visit Drugs.com.

Novarel

Novarel, a leading brand in the production of human chorionic gonadotropin (hCG), is renowned for its high-quality, water-soluble glycoprotein derived from human pregnancy urine. This hormone, composed of alpha and beta subunits, mimics the action of pituitary luteinizing hormone (LH) and has a small degree of follicle-stimulating hormone (FSH) activity, making it crucial for treating infertility and other hormonal imbalances. Novarel is available in vials containing 5,000 and 10,000 USP units, and its solution, when reconstituted, must be refrigerated and used within 30 days. The global hCG market, which includes Novarel, is expected to reach $1,239 million by 2025, growing at a CAGR of 7.6% from 2018 to 2025. Novarel's efficacy in stimulating gonadal steroid hormones and its role in treating prepubertal cryptorchidism and hypogonadotropic hypogonadism make it a significant player in the market.

Ovidrel

Ovidrel, a brand of choriogonadotropin alfa injection, is a highly effective recombinant human Chorionic Gonadotropin (r-hCG) utilized in infertility treatments. Administered subcutaneously, Ovidrel has proven to be clinically and statistically equivalent to urinary-derived hCG products in inducing final follicular maturation and ovulation, boasting an ovulation rate of 91.9% in anovulatory infertile women. The 250 mg dose achieves maximum serum concentration within 12 to 24 hours and has a mean terminal half-life of approximately 29 hours. Studies reveal that Ovidrel is effective in assisted reproductive technologies, retrieving a comparable number of oocytes per patient to that of urinary-derived hCG products. Ovidrel is produced using genetically engineered Chinese hamster ovary (CHO) cells and is available in a sterile, liquid single-dose pre-filled syringe. For more detailed information, visit the FDA's official document.

HCG Plus

Human Chorionic Gonadotropin (hCG) from renowned brands in the market is highly regarded for its quality and efficacy. The global hCG market, featuring products from major companies like Merck & Co. and Ferring B.V., was valued at USD 710.88 million in 2022 and is projected to reach USD 1,176.22 million by 2030, growing at a CAGR of 6.5%. These products are utilized in fertility treatments and are either extracted from the urine of pregnant women or produced through recombinant DNA technology. The market dominance of these brands is due to their robust medical infrastructure and the increasing demand in regions like North America and the Asia-Pacific. The hCG levels detected by these products are integral for pregnancy tests and fertility treatments, with serum assays capable of measuring beta-hCG as low as 1 to 2 mIU/mL. For more detailed insights, check out the Human Chorionic Gonadotropin market report.

MHP

MHP (Maximum Human Performance) is a renowned brand in the sports nutrition and supplement industry, trusted by millions of consumers and elite athletes worldwide for over 25 years. Known for its high-quality and innovative products, MHP has established itself as a leader in helping individuals achieve maximum human performance. Their commitment to quality is evident in their GMP-certified facilities in the USA, ensuring stringent standards are met. MHP's products, such as creatine monohydrate, have been backed by extensive research and are favored for their effectiveness. With a wide range of supplements, MHP continues to empower health and fitness enthusiasts to reach their fullest potential. Discover more about MHP's offerings on their official website.

NutraBlast

NutraBlast, as a reputable brand, is often recognized for its high-quality health supplements, though it is not specifically known for hCG products. In the context of hCG, it is crucial to understand that hCG levels are a critical indicator of pregnancy health, rising rapidly during the first trimester and peaking around weeks 8-11. For accurate hCG measurement, blood tests are more reliable than urine tests. hCG levels can vary widely, with normal ranges at 5-72 mIU/mL at 3 weeks and up to 288,000 mIU/mL by 12 weeks. Healthcare providers use these levels to monitor pregnancy progression and detect potential issues. For more information on hCG testing, visit the Mount Sinai Health Library.

HCG Warrior

HCG Warrior is a leading supplier of HCG drops, boasting over 50,000 satisfied customers since 2010. Their products are manufactured in an FDA-certified facility, ensuring high quality and strict supervision. The brand offers a specific HCG diet plan that promises significant weight loss without the need for exercise, with some users reporting losses of up to 50 pounds over multiple rounds. HCG Warrior provides excellent customer support, with staff who have personally completed the diet. They offer fast shipping, including tracking through Canada Post, ensuring delivery within 2-3 business days in Canada.

Triumph HCG

Triumph HCG is not a recognized brand associated with the production or marketing of human chorionic gonadotropin (HCG) products. The term "Triumph" in the context of HCG is misleading, as there is no credible evidence linking a company named Triumph to the production of HCG products. Instead, companies like Merck & Co., Ferring B.V., and others are prominent in the HCG market. The FTC has also warned against deceptive marketing of HCG products, emphasizing the lack of scientific evidence supporting their weight-loss claims. Therefore, it is crucial to be cautious and skeptical of advertisements promoting HCG for weight loss.

Amirecca

Amidst the growing demand for human chorionic gonadotropin (hCG driven by increasing infertility rates) and the need for assisted reproductive technologies, brands like Amirecca stand out as top producers. The global hCG market, projected to grow at a CAGR of 6.54% from 2024 to 2034, is driven by factors such as the rising prevalence of female infertility and the growing demand for in vitro fertilization (IVF). North America, where 12.1% of women aged 15-44 years suffer from impaired fecundity annually, remains a dominant market for hCG products. Amirecca's products, including recombinant and native hCG, cater to this demand with various strengths and dosages, contributing to the market's anticipated growth to $1,522.76 million by 2034. The brand's commitment to quality and individualized therapy options is crucial in addressing the high prevalence of infertility, such as the 24.58% overall infertility rate reported in 2021.

US HCG Shots

US HCG Shots is a mid-range performing brand in the medical supply category, earning an overall score of 3.9 out of 5 stars based on 49 reviews. The brand competes with other notable medical equipment tools like Mounjaro, Ozempic, and Wegovy. US HCG Shots is recognized for its customer ratings, brand popularity, and competitive pricing. The human chorionic gonadotropin market, which includes products like those from US HCG Shots, is projected to grow at a CAGR of 7.6% from 2021 to 2029, driven by increasing demand for infertility treatments. North America, where US HCG Shots operates, holds a significant market share, with over 38% of the global market in 2022.